Uso de betabloqueantes y el riesgo de muerte en pacientes hospitalizados por exacerbaciones agudas de enfermedad pulmonar obstructiva crónica (EPOC)

por Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Berald CB
Publicado en Revista Americana de Medicina Respiratoria (2008)

Tobacco Smoke Exposure and Socioeconomic Factors Are Independent Predictors of Pulmonary Decline in Pediatric Cystic Fibrosis

por Oates, GR, Baker, E, Rowe, SM, Gutierrez, HH, Schechter, MS, Morgan, W, Harris, WT
Publicado en J Cyst Fibros (2020)

Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation

por Guimbellot, J.S., Baines, A., Paynter, A., Heltshe, S.L., VanDalfsen, J., Jain, M., Rowe, S.M., Sagel, S.D.
Publicado en J Cyst Fibros (2020)

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial

por Rowe SM, Jones I, Dransfield MT, Haque N, Gleason S, Hayes KA, Kulmatycki K, Yates DP, Danahay H, Gosling M, Rowlands DJ, Grant SS
Publicado 2020-10-01

ΔF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers

por Rowe, SM, Pyle, LC, Jurkevante, A, Varga, K, Collawn, J, Sloane, PA, Woodworth, B, Mazur, M, Fulton, J, Fan, L, Li, Y, Fortenberry, J, Sorscher, EJ, Clancy, JP
Publicado 2010

Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats

por Plyler, Z.E., Birket, S.E., Schultz, B.D., Hong, J. S., Rowe, S.M., Petty, C.F., Crowley, M.R., Crossman, D.K., Schoeb, T.R., Sorscher, E.J.
Publicado en Mech Dev (2018)

Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Phe508del and a Residual Function Mutation

por Rowe, S.M., Daines, C., Ringshausen, F.C., Kerem, E., Wilson, J., Tullis, E., Nair, N., Simard, C., Han, L., Ingenito, E.P., McKee, C., Lekstrom-Himes, J., Davies, J.C.
Publicado en N Engl J Med (2017)

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

por Wainwright, C.E., Elborn, J.S., Ramsey, B.W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J.C., De Boeck, K., Flume, P.A., Konstan, M.W., McColley, S.A., McCoy, K., McKone, E.F., Munck, A., Ratjen, F., Rowe, S.M., Waltz, D., Boyle, M.P.
Publicado en N Engl J Med (2015)

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

por Middleton, P.G., Mall, M.A., Dřevínek, P., Lands, L.C., McKone, E.F., Polineni, D., Ramsey, B.W., Taylor-Cousar, J.L., Tullis, E., Vermeulen, F., Marigowda, G., McKee, C.M., Moskowitz, S.M., Nair, N., Savage, J., Simard, C., Tian, S., Waltz, D., Xuan, F., Rowe, S.M., Jain, R.
Publicado en N Engl J Med (2019)